Mice were injected with 150 g/g of D-luciferin (12 mg/mL in PBS) and imaged using a PerkinElmer IVIS Spectrum system
Our endeavor seeks to illuminate the cutting-edge dynamics of current AMS prediction methodologies, scrutinize unresolved issues and challenges, thereby providing authoritative and forward-looking reference points and practical guidance for global researchers and clinicians
Quick Answer: Phentermine and tirzepatide together is an off-label, non-FDA-approved combination with no clinical trial evidence supporting its safety or efficacy
Neuroprotection protocols use 0.25-0.5 mg daily subcutaneously or orally
Chang CH, Tsai WC, Hsu YH, Pang JHS
The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice